SCHEDULE: Divisadero Street Amends AngioDynamics Stake

Divisadero Street Capital Management and related entities filed an amendment to their Schedule 13G, disclosing a passive beneficial ownership of 0.01% in AngioDynamics, Inc. common stock as of December 31, 2025.

Summary

• Divisadero Street Capital Management, LP, William Zolezzi, Divisadero Street Partners, L.P., Divisadero Street Partners GP, LLC, and Divisadero Street Capital, LLC filed an Amendment No. 2 to Schedule 13G for AngioDynamics, Inc.
• The filing reports beneficial ownership of AngioDynamics, Inc. common stock as of December 31, 2025.
• Divisadero Street Capital Management, LP, William Zolezzi, and Divisadero Street Capital, LLC each beneficially own 4,576 shares, representing 0.01% of the class.
• Divisadero Street Partners, L.P. and Divisadero Street Partners GP, LLC each beneficially own 3,513 shares, representing 0.01% of the class.
• All reported shares are held with shared voting and shared dispositive power.
• The securities were not acquired for the purpose of changing or influencing control of AngioDynamics, Inc.
• The shares are directly owned by advisory clients of Divisadero Street Capital Management, LP, with no single client owning more than 5%.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine regulatory disclosure of passive beneficial ownership and does not convey any positive or negative implications for AngioDynamics' operational or financial performance.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by passive investors who own less than 5% of a company's outstanding shares and do not intend to influence control. This filing indicates a minor, passive investment in AngioDynamics, a company operating in the medical device sector, and does not suggest any strategic shifts or significant investor activism.

Related Party Transactions

• William Zolezzi is identified as a control person for Divisadero Street Capital Management, LP and Divisadero Street Capital, LLC, indicating an internal relationship within the reporting group.

Stakeholder Impact

• Minimal impact on shareholders as the reported ownership is a very small, passive stake (0.01%) and does not indicate any intent to influence company control or strategy.
• No direct impact on employees, customers, suppliers, or creditors is implied by this beneficial ownership disclosure.

Key Dates

Recommendation

This Schedule 13G/A filing is a routine disclosure of a passive, very small beneficial ownership stake (0.01%) in AngioDynamics, Inc. It explicitly states no intent to influence control. As such, it provides no new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Investors should continue to hold based on existing fundamental analysis of AngioDynamics.

Keywords

AngioDynamics, Divisadero Street Capital Management, Schedule 13G, Beneficial Ownership, Common Stock, Medical Devices, Healthcare, Investment, Passive Stake